Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

NCT01625156 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

NIH

Sponsor class

Conditions

Adult Solid Neoplasm

Interventions

OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Temsirolimus
DRUG: Tivantinib

Sponsor

National Cancer Institute (NCI)